GSK "Glaxo Smith Kline" WEB PRESENCE
Glaxo Smith Kline
Glaxo Smith Kline has a challenging and inspiring mission: to improve the quality of human life by enabling people to do more, feel better and live longer. This mission gives their purpose to develop innovative medicines and products that help millions of people around the world. In fact, they are the only pharmaceutical company to tackle the World Health Organization's three 'priority' diseases - HIV/AIDS, tuberculosis and malaria.
Headquartered in the UK and with operations based in the US, GSK is one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market. But being a leader brings responsibility. This means that GSK cares about the impact that we have on the people and places touched by our mission to improve health around the world. It also means that GSK must help developing countries where debilitating disease affects millions of people and access to life-changing medicines and vaccines becomes problematic. To meet this challenge, they are committed to providing discounted medicines where they are needed the most.
As a company with a firm foundation in science, GSK has a flair for research and a track record of turning that research into powerful, marketable drugs. Every hour they spend more than £300,000 (US$562,000) to find new medicines. GSK produces medicines that treat six major disease areas - asthma, virus control, infections, mental health, diabetes and digestive conditions. In addition, they are a leader in the important area of vaccines and are developing new treatments for cancer.